The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PSMA PET/CT and mpMRI discrepancies in prostate cancer detection with whole-mount histopathology gold standard.
 
Ida Sonni
No Relationships to Disclose
 
Sahith Doddipalli
No Relationships to Disclose
 
Madhvi Deol
No Relationships to Disclose
 
David Ban
No Relationships to Disclose
 
Hye Ok Kim
No Relationships to Disclose
 
Tristan Grogan
No Relationships to Disclose
 
Preeti Ahuja
No Relationships to Disclose
 
Nashla Barroso
No Relationships to Disclose
 
Yang Zong
No Relationships to Disclose
 
Priti Soin
No Relationships to Disclose
 
Adam B Weiner
No Relationships to Disclose
 
Anthony E Sisk
No Relationships to Disclose
 
Jeremie Calais
Honoraria - Advanced Accelerator Applications; Curium Pharma; EXINI Diagnostics; Novartis; Progenics; Radiomedix
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Blue Earth Diagnostics; Curium Pharma; GE Healthcare; Janssen; Lantheus Medical Imaging; Novartis; POINT Biopharma; Progenics; Radiomedix; Sanofi; SOFIE; Telix Pharmaceuticals
Speakers' Bureau - Lantheus Medical Imaging
Research Funding - Progenics
 
William Hsu
No Relationships to Disclose
 
Robert Evan Reiter
Stock and Other Ownership Interests - ImaginAb
Consulting or Advisory Role - Astellas Pharma
Speakers' Bureau - Bayer Schering Pharma; Genomic Health; ImaginAb; Janssen Oncology; Pfizer
Patents, Royalties, Other Intellectual Property - patents surrounding discovery of PSCA and N-cadherin, owned by UCLA (Inst)
 
Johannes Czernin
Leadership - SOFIE; Trethera
Stock and Other Ownership Interests - SOFIE; Trethera
Consulting or Advisory Role - Advanced Accelerator Applications; Aktis Oncology; Amgen; Jubilant Radiopharma; POINT Biopharma; RayzeBio
 
Steven Raman
No Relationships to Disclose